TFF3 and Barrett esophagus: Accordingly, a minimally invasive non-endoscopic device, the cytosponge-trefoil factor 3 (TFF3), has been recently proposed for the collection of esophageal cells in order to screen GERD patients who warrant endoscopy to diagnose BE [50].